activ doxorubicin cisplatin combin chemotherapi patient diffus malign pleural mesothelioma italian lung cancer task forc fonicap phase II studi twenty-six symptomat patient diffus malign pleural mesothelioma dmpm phase II italian lung cancer task forc fonicap studi activ toxic doxorubicin cisplatin combin chemotherapi drug schedul doxorubicin cisplatin IV day week evalu patient object partial respons confid limit twelv patient radiolog evid respons clinic improv object reduct symptom perform statu treatment overal median surviv time month toxic mild dose reduct suspens combin doxorubicin cisplatin effect palliat symptomat patient dmpm 